Amongst these compounds, carbamazepine, ABT-737, LY294002, oridonin, and paroxetine could restore LC3 puncta in the MPAN fibroblasts, identifying them as novel potential therapeutic compounds to treat MPAN. The gene discussed is MAP1LC3A; the disease is neurodegeneration with brain iron accumulation 4.